FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385814446> ?p ?o ?g. }

• W4385814446 abstract "Per- and polyfluoroalkyl substances (PFAS) are widely used, environmentally ubiquitous, and stable chemicals that have been associated with lower vaccine-induced antibody responses in children; however, data on adults are limited. The drinking water from one of the two waterworks in Ronneby, Sweden, was heavily contaminated for decades with PFAS from firefighting foams, primarily perfluorohexane sulfonic acid and perfluorooctanesulfonic acid (PFOS). Vaccination against SARS-CoV-2 offered a unique opportunity to investigate antibody responses to primary vaccination in adults who had been exposed to PFAS.Our objective was to evaluate associations between PFAS, across a wide range of exposure levels, and antibody responses in adults 5 wk and 6 months after a two-dose vaccination regime against SARS-CoV-2.Adults age 20-60 y from Ronneby (n=309, median PFOS serum level 47 ng/mL, fifth to 95th percentile 4-213 ng/mL) and a group with background exposure (n=47, median PFOS serum level 4 ng/mL) received two doses of the Spikevax (Moderna) mRNA vaccine. The levels of seven PFAS were measured in serum before vaccination. Serum immunoglobulin G antibodies against the SARS-CoV-2 spike antigen (S-Abs) were measured before vaccination and at 5 wk (n=350) and 6 months (n=329) after the second vaccine dose. Linear regression analyses were fitted against current, historical, and prenatal exposure to PFAS, adjusting for sex, age, and smoking, excluding individuals with previous SARS-CoV-2-infection.PFAS exposure, regardless of how it was estimated, was not negatively associated with antibody levels 5 wk [current PFOS: -0.5% S-Abs/PFOS interquartile range (IQR); 95% confidence interval (CI): -8, 7] or 6 months (current PFOS: 3% S-Abs/PFOS IQR; 95% CI: -6, 12) after COVID-19 vaccination.Following a strict study protocol, rigorous study design, and few dropouts, we found no indication that PFAS exposure negatively affected antibody responses to COVID-19 mRNA vaccination for up to 6 months after vaccination. https://doi.org/10.1289/EHP11847." @default.
• W4385814446 created "2023-08-15" @default.
• W4385814446 creator A5003302904 @default.
• W4385814446 creator A5006351017 @default.
• W4385814446 creator A5006376418 @default.
• W4385814446 creator A5015111235 @default.
• W4385814446 creator A5028269879 @default.
• W4385814446 creator A5037582904 @default.
• W4385814446 creator A5040835235 @default.
• W4385814446 creator A5048517179 @default.
• W4385814446 creator A5060002817 @default.
• W4385814446 creator A5070933605 @default.
• W4385814446 creator A5071384333 @default.
• W4385814446 creator A5074529997 @default.
• W4385814446 creator A5077810572 @default.
• W4385814446 creator A5082628678 @default.
• W4385814446 creator A5088404850 @default.
• W4385814446 date "2023-08-01" @default.
• W4385814446 modified "2023-10-02" @default.
• W4385814446 title "High Exposure to Perfluoroalkyl Substances and Antibody Responses to SARS-CoV-2 mRNA Vaccine—an Observational Study in Adults from Ronneby, Sweden" @default.
• W4385814446 cites W1580337756 @default.
• W4385814446 cites W1751780479 @default.
• W4385814446 cites W1986194759 @default.
• W4385814446 cites W2008057044 @default.
• W4385814446 cites W2064994678 @default.
• W4385814446 cites W2143932271 @default.
• W4385814446 cites W2279067822 @default.
• W4385814446 cites W2317877517 @default.
• W4385814446 cites W2399659652 @default.
• W4385814446 cites W2519038435 @default.
• W4385814446 cites W2768329455 @default.
• W4385814446 cites W2892545440 @default.
• W4385814446 cites W2904612650 @default.
• W4385814446 cites W2921553057 @default.
• W4385814446 cites W2968829238 @default.
• W4385814446 cites W3013484569 @default.
• W4385814446 cites W3084301618 @default.
• W4385814446 cites W3087351650 @default.
• W4385814446 cites W3114911023 @default.
• W4385814446 cites W3115056657 @default.
• W4385814446 cites W3133988412 @default.
• W4385814446 cites W3139448134 @default.
• W4385814446 cites W3141147743 @default.
• W4385814446 cites W3192449332 @default.
• W4385814446 cites W3193659507 @default.
• W4385814446 cites W3207559637 @default.
• W4385814446 cites W3214721620 @default.
• W4385814446 cites W4225489846 @default.
• W4385814446 cites W4226097951 @default.
• W4385814446 cites W4226342215 @default.
• W4385814446 cites W4283331044 @default.
• W4385814446 cites W4296620604 @default.
• W4385814446 doi "https://doi.org/10.1289/ehp11847" @default.
• W4385814446 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37578904" @default.
• W4385814446 hasPublicationYear "2023" @default.
• W4385814446 type Work @default.
• W4385814446 citedByCount "1" @default.
• W4385814446 countsByYear W43858144462023 @default.
• W4385814446 crossrefType "journal-article" @default.
• W4385814446 hasAuthorship W4385814446A5003302904 @default.
• W4385814446 hasAuthorship W4385814446A5006351017 @default.
• W4385814446 hasAuthorship W4385814446A5006376418 @default.
• W4385814446 hasAuthorship W4385814446A5015111235 @default.
• W4385814446 hasAuthorship W4385814446A5028269879 @default.
• W4385814446 hasAuthorship W4385814446A5037582904 @default.
• W4385814446 hasAuthorship W4385814446A5040835235 @default.
• W4385814446 hasAuthorship W4385814446A5048517179 @default.
• W4385814446 hasAuthorship W4385814446A5060002817 @default.
• W4385814446 hasAuthorship W4385814446A5070933605 @default.
• W4385814446 hasAuthorship W4385814446A5071384333 @default.
• W4385814446 hasAuthorship W4385814446A5074529997 @default.
• W4385814446 hasAuthorship W4385814446A5077810572 @default.
• W4385814446 hasAuthorship W4385814446A5082628678 @default.
• W4385814446 hasAuthorship W4385814446A5088404850 @default.
• W4385814446 hasConcept C159654299 @default.
• W4385814446 hasConcept C203014093 @default.
• W4385814446 hasConcept C22070199 @default.
• W4385814446 hasConcept C42407357 @default.
• W4385814446 hasConcept C71924100 @default.
• W4385814446 hasConceptScore W4385814446C159654299 @default.
• W4385814446 hasConceptScore W4385814446C203014093 @default.
• W4385814446 hasConceptScore W4385814446C22070199 @default.
• W4385814446 hasConceptScore W4385814446C42407357 @default.
• W4385814446 hasConceptScore W4385814446C71924100 @default.
• W4385814446 hasIssue "8" @default.
• W4385814446 hasLocation W43858144461 @default.
• W4385814446 hasLocation W43858144462 @default.
• W4385814446 hasOpenAccess W4385814446 @default.
• W4385814446 hasPrimaryLocation W43858144461 @default.
• W4385814446 hasRelatedWork W1976091839 @default.
• W4385814446 hasRelatedWork W1977724887 @default.
• W4385814446 hasRelatedWork W1990711002 @default.
• W4385814446 hasRelatedWork W2029074520 @default.
• W4385814446 hasRelatedWork W2045994875 @default.
• W4385814446 hasRelatedWork W2076677334 @default.
• W4385814446 hasRelatedWork W2762077922 @default.
• W4385814446 hasRelatedWork W3044571009 @default.
• W4385814446 hasRelatedWork W4319815297 @default.
• W4385814446 hasRelatedWork W979319891 @default.
• W4385814446 hasVolume "131" @default.

• next